Eucolec

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT EUCOLEC (EUCOLEC)

Composition:

Active substance: chlorophyllipt extract, thick;

1 suppository contains thick chlorophyllipt extract (Eucalypti) (1:15.3-10.76:1) (extractant ethanol 93-96%) (calculated as dry substance) 0.05 g (50 mg);

Excipients: polysorbate, hard fat.

Pharmaceutical form. Suppositories.

Main physicochemical properties: dark green, bullet-shaped suppositories. A white coating on the surface of the suppository is permissible.

Pharmacotherapeutic group. Antimicrobial and antiseptic agents used in gynecology. ATC code G01AX.

Pharmacological properties.

Pharmacodynamics.

The active substance of the medicinal product is chlorophyllipt extract, thick. Chlorophyllipt extract exerts a stimulating effect on mucosal receptors and also has local anti-inflammatory and antiseptic activity.

The drug exhibits antibacterial (bacteriostatic and bactericidal) activity against staphylococci.

Pharmacokinetics.

Not described.

Clinical characteristics.

Indications.

Treatment of infectious-inflammatory processes of the female genital organs (colpitis, vaginitis, vulvovaginitis) and intestines caused by antibiotic-resistant strains of staphylococci.

Contraindications.

Hypersensitivity to chlorophyllipt or to other components of the drug.

Interaction with other medicinal products and other forms of interaction.

There are no data regarding drug interactions.

Special precautions for use.

Consult a physician before starting treatment.

After using the first suppository, a pause of 6–8 hours should be made.

Course treatment with the drug is possible only after confirming the absence of allergic reactions to the dense chlorophyllipt extract (possible swelling of the lips, nasal mucosa, pharynx, and other allergic reactions). If any of the above symptoms occur, the use of the medicinal product must be discontinued and medical advice should be sought.

Use during pregnancy or breastfeeding.

The efficacy and safety of the drug during pregnancy or breastfeeding have not been studied; therefore, the drug should not be used in these patient groups.

Ability to influence reaction rate while driving or operating machinery.

No data available.

Method of Administration and Dosage

Before using the suppository, it is necessary to:

• tear off one suppository in the primary packaging along the perforation line of the blister pack;
• pull the edges of the film in opposite directions, tearing it apart, and remove the suppository from the primary packaging.

The drug is intended for vaginal and rectal administration.

Dosage for adults: 1 suppository twice daily. Treatment duration: 10–14 days.

Children.

There is no experience with the use of the drug for the treatment of children.

Overdose.

Main symptoms of overdose: swelling of the lips, nasal mucosa, and pharynx.

Treatment: discontinue the drug. Symptomatic treatment.

Side effects.

Immune system side effects: allergic reactions, including itching, rash, hyperemia, angioedema (possible swelling of lips, nasal mucosa, pharynx, etc.).

Shelf life.

2 years.

Storage conditions.

Store in the original packaging, out of reach of children, at a temperature not exceeding 25 °C.

Packaging.

5 suppositories per blister; 1 or 2 blisters per carton.

Availability.

Over-the-counter.

Manufacturer.

Private Joint-Stock Company "Lekhim-Kharkiv".

Manufacturer's address and location of business activity.

36 Severina Pototskoho Street, Kharkiv, Kharkiv Region, 61115, Ukraine.